TY - JOUR
T1 - Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
AU - Ben-Shmuel, Aviad
AU - Gruper, Yael
AU - Halperin, Coral
AU - Levi-Galibov, Oshrat
AU - Rosenberg-Fogler, Hallel
AU - Barki, Debra
AU - Carradori, Giulia
AU - Stein, Yaniv
AU - Yagel, Gal
AU - Naumova, Mariia
AU - Mayer, Shimrit
AU - Dadiani, Maya
AU - Morzaev-Sulzbach, Dana
AU - Golani, Ofra
AU - Nevo, Reinat
AU - Porat, Ziv
AU - Nili Gal-Yam, Einav
AU - Scherz-Shouval, Ruth
N1 - Publisher Copyright:
©2025 American Association for Cancer Research.
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.
AB - Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.
UR - https://www.scopus.com/pages/publications/105008294217
U2 - 10.1158/2159-8290.CD-24-0131
DO - 10.1158/2159-8290.CD-24-0131
M3 - Article
C2 - 40052789
AN - SCOPUS:105008294217
SN - 2159-8274
VL - 15
SP - 1247
EP - 1269
JO - Cancer Discovery
JF - Cancer Discovery
IS - 6
ER -